Childhood diet can modify the gut microbiome for life Kumar Jeetendra | February 3, 2021 Eating too much fat and sugar for a child can alter your microbiome for life, even if you later learn to eat healthier, a new study in mice suggests. The study by UC Riverside researchers is among the first to demonstrate a significant decrease in the total number and diversity of gut bacteria in mature …
BD Announces Assay for Identification of COVID-19 Patients Kumar Jeetendra | February 3, 2021 EYSINS, Switzerland, February 03, 2021/BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE mark of BD Multitest™ 6-Color TBNK Reagent with BD Trucount™ Tubes with expanded clinical application to help clinicians identify COVID-19 patients at increased relative risk of intubation with mechanical ventilation (IMV) and mortality at …
Glenmark Pharma gets USFDA gesture for seizure treatment drug Kumar Jeetendra | February 4, 2021 Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Topiramate extended-release capsules, used to treat certain types of seizures. The approved product is a generic version of Qudexy XR Capsules of Upsher-Smith Laboratories, LLC. Glenmark Pharmaceuticals Ltd has received final approval from the United States Food …
World first – biological evidence reveals scalp cooling physically protects hair from chemotherapy Kumar Jeetendra | February 4, 2021 Huddersfield, UK – 4 February 2021 – Groundbreaking research, announced ahead of World Cancer Day 2021, proves that scalp cooling physically protects hair follicles from chemotherapy drugs. It is the world’s first piece of biological evidence that explains how scalp cooling actually works and the mechanism behind its protection of the hair follicle. The study, …
North Korea expected to get almost 2 million dosages of AstraZeneca-Oxford COVID-19 antibody by June Kumar Jeetendra | February 4, 2021 North Korea is expected to receive almost two million doses of AstraZeneca-Oxford COVID-19 vaccine by the first half of 2021, Yonhap reported on Thursday, citing a report published by COVAX Facility on Wednesday. The COVAX Facility will distribute 1.992 million doses of AstraZeneca/Oxford vaccines created by the Serum Institute of India to the North Korea …
Serum Institute of India postpones antibodies for private sale in Bangladesh; center around state campaigns Kumar Jeetendra | February 4, 2021 Bangladesh’s Beximco Pharmaceuticals Ltd said on Thursday the Serum Institute of India (SII) had delayed the first supplies of a COVID-19 vaccine for personal sale, instead prioritising government immunisation campaigns. Beximco is Bangladesh’s exclusive distributor of the Oxford University-AstraZeneca shot that SII, the world’s biggest vaccine maker, is producing in bulk for low- and medium-income …
Resonance-guided vaporization may give better approaches for treating tumors Kumar Jeetendra | February 4, 2021 Sending tiny droplets to a tumor and having them vaporized using focused ultrasound: it might be a new way of tracing a tumor or send drugs locally. Researchers of the University of Twente in The Netherlands now demonstrate a new phenomenon triggering droplet vaporization: it occurs at the exact acoustic resonance frequency and causes fast …
Sulforaphane draws out life expectancy and healthspan of C. elegans through insulin/IGF-1 flagging Kumar Jeetendra | February 4, 2021 Aging-US released”Sulforaphane boosts C. elegans longevity and healthspan through DAF- 16/DAF-2 insulin/IGF-1 signaling” which reported that the broccoli-derived isothiocyanate sulforaphane inhibits inflammation, oxidative stress and cancer, but its impact on healthspan and longevity are unclear. The writers used the C. elegans nematode version and fed the wildtype and 9 mutant strains ±sulforaphane. Sulforaphane increased the …
Johnson and Johnson files COVID-19 immunization application with US FDA Kumar Jeetendra | February 5, 2021 Johnson & Johnson said it has asked US health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it’ll apply to European authorities in coming weeks. The drugmaker’s application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report where it said the vaccine had a 66% rate of preventing …
Gene panel test empowers exceptionally exact diagnosis of liposarcomas Kumar Jeetendra | February 5, 2021 Scientists have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel evaluation which allows for highly accurate diagnosis of the most frequent kinds of liposarcoma. The new assay is described in The Journal of Molecular Diagnosis, published by Elsevier. Liposarcomas are a type of malignant cancer that is …
Essential Screening for microbial evolution research via INTEGRA’s electronic pipettes Kumar Jeetendra | February 5, 2021 Bacterial evolution studies involve analysis of large sample numbers, requiring streamlined, reproducible pipetting processes to effectively characterize the features of different strains. Dr Astrid Altamirano-Junqueira, who completed her doctoral studies into the evolution of bacterial motility in the School of Biological Studies at Reading University, discussed how these electronic pipettes aided her research: “My focus …
Oxford says COVID-19 immunization with AstraZeneca neutralizes UK variant Kumar Jeetendra | February 6, 2021 AstraZeneca and Oxford University’s COVID-19 vaccine has similar efficacy against the British coronavirus version as it does to the previously circulating variants, the university said on Friday. The version, first identified in Kent, southern England, is more readily transmissible, prompting many countries to limit travel to Britain. It also led to a spike in infections …
